GENE/Var_N	#CHROM	POS	REF	ALT	FILTER	GNOMAD_VAR	AC	SYMBOL	Consequence	IMPACT	HGVSc	HGVSp	cDNA_position	CDS_position	Protein_position	Amino_acids	Codons	EXON	INTRON	CANONICAL	CCDS	BIOTYPE	Gene	Feature_type	Feature	ENSP	DOMAINS	MAX_AF	MAX_AF_POPS	gnomAD_exomes_AC	gnomAD_genomes_AC	ExAC_Adj_AC	ALSPAC_AC	TWINSUK_AC	SIFT	PolyPhen	CADD_PHRED	M-CAP_pred	phyloP100way_vertebrate	ada_score	rf_score	SpliceRegion	Existing_variation	GENE_PHENO	CLIN_SIG	clinvar_clnsig	clinvar_golden_stars	clinvar_rs	clinvar_trait	SOMATIC	PHENO	PUBMED	CSN	DISTANCE	STRAND	FLAGS	VARIANT_CLASS	SYMBOL_SOURCE	HGNC_ID	Allele	HGVS_OFFSET	BOEX_CL004	BOEX_CL005	BOEX_CL006	Marfan_Syndrome	Gene_old_names	Gene_other_names	Refseq_id	ucsc_id	MIM_id	Gene_full_name	Pathway(Uniprot)	Pathway(KEGG)_full	Function_description	Disease_description	MIM_phenotype_id	MIM_disease	GO_biological_process	GO_cellular_component	GO_molecular_function	Tissue_specificity(Uniprot)	Expression(GNF/Atlas)	Interactions(BioGRID)	Interactions(ConsensusPathDB)	RVIS_percentile_ExAC	ExAC_pLI	ExAC_pRec	ExAC_pNull	MGI_mouse_gene	MGI_mouse_phenotype	ZFIN_zebrafish_gene	ZFIN_zebrafish_structure	ZFIN_zebrafish_phenotype_quality	ZFIN_zebrafish_phenotype_tag
TRPM1/1	15	31362352	C	T	SB	http://gnomad.broadinstitute.org/variant/15-31362352-C-T	6	TRPM1	missense_variant	MODERATE	ENST00000559179.1:c.95G>A	ENSP00000453851.1:p.Ser32Asn	229	95	32	S/N	aGc/aAc	3/3			CCDS58345.1	protein_coding	http://gnomad.broadinstitute.org/gene/ENSG00000134160	Transcript	ENST00000559179	ENSP00000453851	hmmpanther:PTHR13800&hmmpanther:PTHR13800:SF13	0.0009481	gnomAD_EAS	198200	24763	96492	3131	3019	tolerated(0.6)	benign(0)	3.281		-0.642000				rs2241493	1	benign	2&2	1&1	rs2241493	not_specified&Congenital_Stationary_Night_Blindness&_Recessive		1	19896113&24019741&19878917&21439949	ENST00000559179.1:c.95G>A_p.Ser32Asn		-1		SNV	HGNC	7146	T		0/1	0/1	0/0	NA	MLSN1	LTRPC1;CSNB1C	NM_002420;NM_001252020	uc001zfm.4	https://www.omim.org/entry/603576	transient receptor potential cation channel subfamily M member 1	.	.	FUNCTION: Cation channel essential for the depolarizing photoresponse of retinal ON bipolar cells. It is part of the GRM6 signaling cascade. May play a role in metastasis suppression (By similarity). May act as a spontaneously active, calcium-permeable plasma membrane channel. {ECO:0000250, ECO:0000269|PubMed:11535825, ECO:0000269|PubMed:19878917, ECO:0000269|PubMed:19896109}.; 	DISEASE: Night blindness, congenital stationary, 1C (CSNB1C) [MIM:613216]: A non-progressive retinal disorder characterized by impaired night vision, often associated with nystagmus and myopia. {ECO:0000269|PubMed:19878917, ECO:0000269|PubMed:19896109, ECO:0000269|PubMed:19896113}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	613216;	[MIM:613216]Night blindness, congenital stationary, 1C;	transport;G-protein coupled glutamate receptor signaling pathway;visual perception;retinal rod cell development;protein tetramerization;calcium ion transport into cytosol;calcium ion transmembrane transport;cellular response to light stimulus	plasma membrane;integral component of plasma membrane;new growing cell tip	calcium channel activity	TISSUE SPECIFICITY: Expressed in the retina where it localizes to the outer plexiform layer. Highly expressed in benign melanocytic nevi and diffusely expressed in various in situ melanomas, but not detected in melanoma metastases. Also expressed in melanocytes and pigmented metastatic melanoma cell lines. In melanocytes expression appears to be regulated at the level of transcription and mRNA processing. {ECO:0000269|PubMed:11112417, ECO:0000269|PubMed:19896109, ECO:0000269|PubMed:9537257}.; 	superior cervical ganglion;	TRPM1[11535825];NANOG[26687479];BCOR[26687479];POU5F1[26687479];	FXR1[0.014];BCOR[0.014];NANOG[0.014];POU5F1[0.015]	85.3864225	1.16831980652389e-31	0.000371176768014892	0.999628823231985	Trpm1	behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 	.	.	.	.
TRPM1/1	15	31453147	G	A	PASS	http://gnomad.broadinstitute.org/variant/15-31453147-G-A	2	TRPM1	missense_variant	MODERATE	ENST00000542188.1:c.16C>T	ENSP00000437849.1:p.Arg6Trp	330	16	6	R/W	Cgg/Tgg	1/27		YES	CCDS58347.1	protein_coding	http://gnomad.broadinstitute.org/gene/ENSG00000134160	Transcript	ENST00000542188	ENSP00000437849	hmmpanther:PTHR13800&hmmpanther:PTHR13800:SF13	0.0000175	EUR	12518	3199	928	569	564	deleterious_low_confidence(0)	probably_damaging(0.972)	23.1		2.330000				rs75638145	1								19878917	ENST00000542188.1:c.16C>T_p.Arg6Trp		-1		SNV	HGNC	7146	A		0/1	0/0	0/1	NA	MLSN1	LTRPC1;CSNB1C	NM_002420;NM_001252020	uc001zfm.4	https://www.omim.org/entry/603576	transient receptor potential cation channel subfamily M member 1	.	.	FUNCTION: Cation channel essential for the depolarizing photoresponse of retinal ON bipolar cells. It is part of the GRM6 signaling cascade. May play a role in metastasis suppression (By similarity). May act as a spontaneously active, calcium-permeable plasma membrane channel. {ECO:0000250, ECO:0000269|PubMed:11535825, ECO:0000269|PubMed:19878917, ECO:0000269|PubMed:19896109}.; 	DISEASE: Night blindness, congenital stationary, 1C (CSNB1C) [MIM:613216]: A non-progressive retinal disorder characterized by impaired night vision, often associated with nystagmus and myopia. {ECO:0000269|PubMed:19878917, ECO:0000269|PubMed:19896109, ECO:0000269|PubMed:19896113}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	613216;	[MIM:613216]Night blindness, congenital stationary, 1C;	transport;G-protein coupled glutamate receptor signaling pathway;visual perception;retinal rod cell development;protein tetramerization;calcium ion transport into cytosol;calcium ion transmembrane transport;cellular response to light stimulus	plasma membrane;integral component of plasma membrane;new growing cell tip	calcium channel activity	TISSUE SPECIFICITY: Expressed in the retina where it localizes to the outer plexiform layer. Highly expressed in benign melanocytic nevi and diffusely expressed in various in situ melanomas, but not detected in melanoma metastases. Also expressed in melanocytes and pigmented metastatic melanoma cell lines. In melanocytes expression appears to be regulated at the level of transcription and mRNA processing. {ECO:0000269|PubMed:11112417, ECO:0000269|PubMed:19896109, ECO:0000269|PubMed:9537257}.; 	superior cervical ganglion;	TRPM1[11535825];NANOG[26687479];BCOR[26687479];POU5F1[26687479];	FXR1[0.014];BCOR[0.014];NANOG[0.014];POU5F1[0.015]	85.3864225	1.16831980652389e-31	0.000371176768014892	0.999628823231985	Trpm1	behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); 	.	.	.	.
